Search Results - "Mezzabotta, Mauro"

The use of erythropoiesis‐stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib by Crisà, Elena, Cilloni, Daniela, Elli, Elena M., Martinelli, Vincenzo, Palumbo, Giuseppe A., Pugliese, Novella, Beggiato, Eloise, Frairia, Chiara, Cerrano, Marco, Lanzarone, Giuseppe, Marchetti, Monia, Mezzabotta, Mauro, Boccadoro, Mario, Ferrero, Dario

“…Summary Erythropoiesis‐stimulating agents (ESAs) were combined with ruxolitinib in 59 anaemic myelofibrosis patients (93% with Dynamic International Prognostic…”
Get full text

Clinical Outcomes of 420 MDS Patients Treated with 5-Azacytidine: Evaluation of Overall Survival, Duration of Treatment and Rate of Discontinuation in a Real Life Study from the Italian MDS Registry of Fondazione Italiana Sindromi Mielodisplastiche (FISM) by Clavio, Marino, Gioia, Daniela, Ceccarelli, Manuela, Monagheddu, Chiara, Balleari, Enrico, Miglino, Maurizio, Di Tucci, Anna Angela, Allione, Bernardino, Poloni, Antonella, Finelli, Carlo, Aguzzi, Chiara, Selleri, Carmine, Danise, Paolo, Cilloni, Daniela, Gaidano, Valentina, Cavaliere, Marina, Calzamiglia, Tullio, Freilone, Roberto, Cametti, Gianni, Conconi, Anna Rita, Mezzabotta, Mauro, Goretti, Riccardo, Musto, Pellegrino, Gaidano, Gianluca, Pane, Fabrizio, Angelucci, Emanuele, Levis, Alessandro, Santini, Valeria

“…▪ Introduction Azacytidine(AZA) is the current standard of care for patients with high-risk myelodysplastic syndrome (MDS) in Europe. AZA has shown a survival…”
Get full text

Serum levels of erythropoietin and soluble transferrin receptor during pregnancy in non-β-thalassemic and β-thalassemic women by BIANCO, Ida, MASTROPIETRO, Fabrizio, D'ASERO, Carmelo, GRAZIANI, Bruno, PIERGROSSI, Piero, MEZZABOTTA, Mauro, MODIANO, Guido

Get full text

Phenotypes of individuals with a beta thal classical allele associated either with a beta thal silent allele or with alpha globin gene triplication by Bianco, I, Lerone, M, Foglietta, E, Deidda, G, Cappabianca, MP, Morlupi, L, Ponzini, D, Grisanti, P, Di Biagio, P, Amato, A, Mezzabotta, M, Graziani, B

“…Associazione Nazionale per la Lotta contro le Microcitemie in Italia, Rome. BACKGROUND AND OBJECTIVE: beta thalassemia intermedia has its origins in compound…”
Get full text

Factors regulating Hb F synthesis in thalassemic diseases by Mastropietro, Fabrizio, Modiano, Guido, Cappabianca, Maria, Foglietta, Enrica, D'Asero, Carmelo, Mezzabotta, Mauro, Ponzini, Donatella, Maffei, Laura, Amato, Antonio, Lerone, Maria, Grisanti, Paola, Di Biagio, Paola, Rinaldi, Silvana, Bianco, Ida

“…BACKGROUND: The thalassemic syndromes originate from mutations of the globin genes that cause, besides the characteristic clinical picture, also an increased…”
Get full text